Fig. 5From: Efficacy and safety of cinacalcet compared with other treatments for secondary hyperparathyroidism in patients with chronic kidney disease or end-stage renal disease: a meta-analysisPooled risk ratio of adverse events with cinacalcet versus control treatment in patients with chronic kidney disease. A) Nausea; B) Vomiting; C) Hypercalcemia; D) HypocalcemiaBack to article page